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A B S T R A C T
Mycobacterium tuberculosis (MTB) Central Asian Strain (CAS) lineage strains are predominant
in South Asia. Mycobacterial interspersed repetitive units-variable number of tandem
repeats (MIRU-VNTR) typing is an effective way of determining genetic diversity of strains.
A maximum of 24 loci-based MIRU-VNTR typing can be used, however, it is important to
investigate the relevance of specific MIRU loci for regional strains for more cost-effective
MIRU typing.
MIRU-VNTR typing was performed on MTB strains from Pakistan. Strains were comprised
of CAS (n = 113) and non-CAS lineages (n = 87) – both multi-drug resistant (MDR) and drug
susceptible. Hunter Gaston Discriminatory Index (HGDI) for each MIRU loci was interpreted
as poor, moderate or highly discriminatory. Results were analyzed using Bionumerics
software and miru-vntrplus database link.
Clustering analysis revealed 185 different MIRU types. Eight clusters of 2 strains each
were present amongst MDR (3 clusters) and drug susceptible (5 clusters) isolates. MDR
clusters had orphan and Haarlem strains, whereas drug susceptible strain clusters were
comprised of CAS and Beijing lineage strains.
The HGDI for 15 loci-based MIRU typing of all isolates was 0.620, whereas HGDI for CAS
was lower than non-CAS lineage strains (p-value: 0.023). HGDI of 8 MIRU-VNTR loci (Qub
26b, 10, 26, 4156, Mtub 04, 16, 31 and ETR-A) were all highly discriminatory. The average
HGDI based on these 8 loci was significantly lower for CAS than non-CAS strains (P value:
0.03).
The lower discriminatory index for CAS using both 15 and 8 MIRU loci-based analysis
suggests less genetic diversity in these isolates than in other lineages. The eight highly
discriminatory MIRU loci for CAS may help in monitoring the transmission of MTB strains
in regions with high CAS lineage prevalence.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.
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Introduction
Mycobacterium tuberculosis (MTB) infects one third of the global
population resulting in 4700 deaths each day [1]. The World
Health Organization (WHO) estimates show that the incidence
of tuberculosis (TB) in Pakistan increased from 181/100,000 to
231/100,000 population between 2006 and 2011 [1,2]. Increasing
rates of resistance to anti-tuberculous drugs amongst MTB
strains has added to the burden caused by TB [3]. Multi-drug
resistant tuberculosis (MDR-TB) is defined as strains resistant
to the first-line drugs (rifampicin and isoniazid), while exten-
sive drug resistant tuberculosis (XDR-TB) is defined as MDR
strains resistant to fluoroquinolone and also an aminoglyco-
side drug. Molecular epidemiology can assist TB control
through identification of predominant MTB strain types,
detection and confirmation of outbreaks, and monitoring of
disease transmission, which may be especially important in
MDR-TB cases [4]. Genomic diversity of MTB is low as com-
pared with other bacteria, and therefore molecular typing
methods are mostly based on polymorphisms in repetitive
genomic sequences of MTB [5], including IS6110-restriction
fragment length polymorphism (IS6110-RFLP), spacer-oligonu-
cleotyping (spoligotyping) and mycobacterial interspersed
repetitive units-variable number of tandem repeats (MIRU-
VNTR) typing.While IS6110RFLP-based typing is used as a gold
standard for MTB typing, 24 loci-based MIRU-VNTR typing is
demonstrated to have a similar discriminatory power [6,7].
Studies fromAsia, Europe and Africa have shown a variable
association between drug resistance andMTB lineages. Beijing
strains have been shown to be associated with MDR and XDR-
TB in several studies [8–10]. However, other studies from
Africa do not show any association between the Beijing strain
and drug resistance of isolates [11]. In Pakistan, the Beijing and
Haarlem strains have been associated with MDR-TB [12–14].
Although 24 loci-based MIRU typing is highly discrimina-
tory, it is costly for resource-limited endemic settings. Genetic
diversity of strains varies between geographical regions and
certain MIRU loci are shown to be more discriminatory than
others; therefore, specific MIRU loci are potentially more use-
ful for typing predominant strains [6,15,16]. For Beijing strains
in South Korea and China, a set of 8 loci of the 24-loci MIRU-
VNTR standard set or alternately a set of 10 out of the 15-loci
MIRU-VNTR standard set of alleles has been proposed for
typing MTB strains [6,16].
In Pakistan, from the 12 loci-based MIRU typing standard
set, 7 MIRU loci, i.e., 10, 16, 26, 27, 31, 39 and 40, were reported
as being highly discriminatory for CAS1 strains [17]. Informa-
tion on 15 loci MIRU typing on MTB isolates from Pakistan
was not available; therefore, to identify a smaller but compre-
hensive set of loci for typing of local strains, the utility of 15
loci typing for both drug susceptible and drug resistant iso-
lates was investigated.
Material and methods
Strain selection
The Aga Khan University (AKU) laboratory has a wide drug
susceptibility testing (DST) network; it receives specimens
collected through more than 180 collection units located in
major cities and towns across the country. All specimens
from collection units are sent to the main clinical laboratory
at Aga Khan University Hospital (AKUH), Karachi, for TB cul-
tures and DST. Over the past 4 years, AKU received 12,000–
15,000 specimens annually for MTB culture with a 15–20%
positivity rate. MTB susceptibility testing is further validated
by the WHO Supranational Laboratory quality assurance pro-
gram. MTB strains (N = 200) were randomly selected from the
mycobacterial strain bank of the clinical laboratory of the
AKUH collected during the time period 2006–2009. Of these,
there were drug susceptible (n = 99) strains, MDR (n = 41) and
XDR strains (n = 60). MTB strain typing received approval from
the Ethical Review Committee of the AKU. These strains were
previously spoligotyped for a cross-sectional study from Paki-
stan [12,18].
Strain types and drug susceptibility pattern
The strains (n = 200) included Central Asian Strain (CAS) (n:
113, 56.5%) and non-CAS(n: 87, 43.5%), including: Beijing, East
African Indian (EAI) and Haarlem (n = 10, 5% each), T family
(n = 12, 6%), Ural family (n = 7, 3.5%), LAM (n = 2, 1%), X3
(n = 1, 0.5%), unique clusters (n = 9, 4.5%), and orphan strains
(n = 28, 14%). Of these, 99 (49.5%) isolates were susceptible to
all first- and second-line anti-tuberculosis drugs: 41 (20.5%)
were MDR and 60 (30%) were XDR (Table 1).
Culture and drug susceptibility testing
MTB strains were isolated from the specimens using Lowen-
stein–Jensen media and MGIT (Becton Dickinson, Franklin
Lakes, NJ, USA). MTB was identified using BACTEC NAP TB
differentiation test (Becton Dickinson), growth on para-
nitrobenzoic acid containing media, nitrate reduction, and
niacin accumulation [19]. Drug susceptibility testing of these
isolates was previously performed using an agar proportion
method on enriched Middlebrook 7H10 medium (BBL Microbi-
ology Systems, Cockeysville, MD, USA) at the following
concentrations: rifampicin 1 lg/mL, isoniazid 0.2 lg/mL,
streptomycin 2 lg/mL and 10 lg/mL, and ethambutol 5 lg/
mL. Pyrazinamide sensitivity was determined by using BAC-
TEC 7H12 medium, pH 6.0, at 100 lg/mL (BACTEC PZA test
medium, Becton Dickinson). MDR TB strains were further
tested with capreomycin 10 lg/mL, ciprofloxacin 2 lg/mL,
ethionamide 5 lg/mL, amikacin 5 lg/mL, and kanamycin
6 lg/mL. Reference strain M. tuberculosis H37Rv was used as
a control with each susceptibility testing batch [20]. The hos-
pital and its clinical laboratory are accredited by the Joint
Commission of International Accreditation (JCIA) and desig-
nated as a technical partner of the National TB program
(NTP). The laboratory participates in the College of American
Pathologists’ proficiency testing program for mycobacterial
identification and sensitivity.
Mycobacterial interspersed repetitive units-variable number
tandem repeats (MIRU-VNTR) typing
Selected isolates were MIRU typed by PCR amplification of the
15 MIRU-VNTR loci as previously described by Supply et al. [7].
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PCRs were carried out in 25 ll volume using 0.4 lM specific
primers, 0.5 mM dNTPs mix, 1 mM MgCl2, 1· PCR buffer, 4%
DMSO and 1U of Super TthTaq DNA polymerase. Approxi-
mately 40–60 ng of template DNAwas added for each reaction.
The following cycling condition for PCR was used: 15 min at
95 C, followed by 35 cycles of 1 min at 94 C, 1 min at 59 C,
and 1 min 30 s at 72 C, which was followed by an extension
of 72 C. The PCR products were electrophoresed on a 3% aga-
rose gel and sizedwith a 100-bp ladder (Promega). All the reac-
tions were performed in duplicates using standard positive
and negative controls supplied in the MIRU-VNTR validation
kit. Sizing of the PCR fragments and assignment of the various
VNTR alleles were also done using standard protocol (Philip
Supply INSERM U629, Institut de Biologie/Institut Pasteur de
Lille-May 2005, www.genoscreen.com).
Analysis of allelic diversity of MIRU-VNTR loci and clustering
All the MIRU loci were individually interpreted as poorly,
moderately and highly discriminatory based on their Hunter
Gaston Discriminatory Index (HGDI) as described previously
[21,22]. HGDI was defined as: highly discriminatory, >0.6;
moderately discriminatory (0.6–0.3); and poorly discrimina-
tory, <0.3. Genetic relatedness among the isolates were
estimated by the unweighted pair group method with arith-
metic averages (UPGMA) using the international database link
for MIRU typing (www.miruvntr-plus) and a dendrogram that
was generated for cluster analysis. A cluster was defined as
two or more MTB strains exhibiting zero distance cut-off
and identical MIRU-VNTR and spoligotype patterns. The 15
loci MIRU patterns were also compared with the patterns
from the MIRU-VNTRplus database to identify MTB strain lin-
eages and relatedness.
Statistical analysis
HGDI of MIRU loci for MTB isolates were analyzed using SPSS
version 19 software. Pearson’s chi-square or Fisher-exact test
was used to calculate the statistical significance. A p value
<0.05 was considered significant.
Results
Demographic information
MTB isolates and XDR isolates were collected from four prov-
inces: Sind, Punjab, Khyber Pakhtunkhwa (KPK) and Baluchis-
tan (Table 2). MTB isolates were obtained from both male and
female patients, with a mean age of 31.8 years. The propor-
tion of male and female patients was 52% (mean age = 32.7 -
years) and 48% (mean age = 30.8 years), respectively.
Cluster analysis
Data from 15 loci based MIRU patterns obtained for 200 MTB
strains were entered in an international database link
Table 2 – Demographic information of patients from whom MTB samples were collected.
Sampling location Gender Mean age (Years) Total sample (N = 200)
Male Female
Sind 88 81 30.2 169
Punjab 10 11 41.7 21
KPK* 5 2 35.6 7
Baluchistan 1 2 45 3
Total 104 96
* KPK = Khyber Pakhtunkhwa.
Table 1 – Distribution of spoligotypes and drug susceptibility profile of Mycobacterium tuberculosis isolates (N: 200).
Spoligotype No. of strain Drug resistance profile
Susceptible MDR XDR
CAS 113 58 20 35
Non-CAS 87 41 21 25
Beijing 10 3 2 5
EAI 10 9 – 1
Haarlem 10 1 9 –
T 12 7 1 4
Ural 5 2 1 2
LAM 2 – 2 –
X3 1 – – 1
Unique cluster 9 9 – –
Orphan strains 28 10 6 12
Total 200 99 41 60
Distribution of MTB spoligotypes and drug susceptibility profiles exhibiting around 50% susceptible and 50% MDR and XDR isolates among the
selected MTB strains.
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Fig. 1 – Fifteen loci MIRU-VNTR dendrogram of 200 MTB isolates. Dendrogram generated by unweighted pair group method
with arithmetic averages (UPGMA) using www.miru-vntrplus.org link. MIRU-VNTR typing differentiated isolates into 7
clusters, of these, 5 clusters had similar MIRU and spoligotype profiles (identified as cluster 1 to cluster 5 in the figure),
whereas the remaining two clusters had similar MIRU profiles but different spoligotype patterns (identified in a box in the
figure). The remaining 186 strains revealed non-matching MIRU profiles.
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(www.miru-vntrplus.org) for cluster analysis. Five clusters of
two strains each were found with identical MIRU and spoligo-
type patterns (Fig. 1). Clusters 1, 2 and 3 were comprised of
drug susceptible CAS strains, Cluster 4 was comprised of
Haarlem strains resistant to ethambutol, rifampicin, pyrazin-
amide, amikacin and capreomycin and Cluster 5 comprised of
drug susceptible Beijing strains (Supplementary File 1). There
were also two clusters of two strains each which had identical
MIRU profiles but different spoligotype patterns; one was a
cluster of MDR strains and the other, of a non-MDR and a
susceptible strain (Fig. 1 and Supplementary File 1). The
remaining 186 strains had differing MIRU patterns.
Furthermore, none of the MIRU profile of our strains
matched with the strains in the international MIRU-VNTRplus
database (Supplementary File 2).
Allelic diversity of individual 15 MIRU loci
Allelic diversity for each of the 15 MIRU loci was also deter-
mined for all isolates. The allelic diversity of the standard15
Table 4 – Comparative Hunter Gaston Discriminatory Index (HGDI) of individual 15 MIRU loci for CAS
and non-CAS MTB isolates.
MIRU loci HGDI of P-value
CAS strains (n = 113) Non-CAS strains (n = 87)
Qub 26 0.807 0.841 0.235
10 0.699 0.835 0.00*
26 0.686 0.854 0.00*
4156 0.699 0.775 0.004*
Mtub4 0.742 0.721 0.004*
16 0.672 0.755 0.001*
31 0.712 0.745 0.056
ETR-A 0.425 0.75 0.046*
40 0.565 0.613 0.095
Mtub39 0.495 0.616 0.037*
Mtub21 0.394 0.691 0.0001*
Mtub30 0.424 0.597 0.0702
ETR-C 0.168 0.619 0.045*
Qub 11b 0.215 0.591 0.002*
4 0.035 0.29 0.004*
DI of 15 loci set 0.517 0.691 0.023**
HGDI for CAS and other than CAS strains displayed in ascending order reveals comparatively lower DIs for CAS1
strains. This difference was found significant (p-value = 0.023).
* Allelic variability for respective locus between CAS and other than CAS strains is significantly different.
** Average DI of CAS and other than CAS strains was significantly different.
Table 3 – Allelic diversity of each of the 15 MIRU-VNTR loci for MTB isolates (N: 200).
MIRU loci Allele number Allelic diversity Rank Discriminatory index (DI)#
0 1 2 3 4 5 6 7 8 9 10 11 12 13 ND*
Qub 26b 1 10 8 11 19 25 51 53 19 1 1 1 0.826 1 High
10 3 26 23 20 56 53 15 2 1 1 0.807 2 High
26 3 16 6 19 37 22 74 16 5 2 0.797 3 High
4156 3 16 46 19 71 29 7 3 3 2 1 0.784 4 High
Mtub04 6 46 38 63 38 6 2 1 0.777 5 High
16 11 12 44 78 36 14 1 4 0.749 6 High
31 6 40 49 80 25 0.727 7 High
ETRA 2 14 43 115 15 9 2 0.613 8 High
40 1 9 27 120 38 4 1 0.586 9 Moderate
Mtub39 11 125 46 11 5 2 0.552 10 Moderate
Mtub21 1 18 24 130 21 4 1 1 0.546 11 Moderate
Mtub30 19 134 4 39 4 0.505 12 Moderate
ETRC 4 135 8 47 6 0.488 13 Moderate
Qub 11b 6 154 10 10 7 10 3 0.399 14 Moderate
4 1 184 2 4 7 1 1 0.144 15 Poor
Average = 0.620
The table shows average as well as individual allelic diversity index of MIRU loci for MTB isolates. Eight MIRU loci were characterized as highly
discriminant (HGDIP 0.6), six as moderately discriminant (HGDI < 0.6 > 0.3) and one poorly discriminant (HGD1 < 0.3).
* ND = no amplification detected.
# DI; high (>0.6), moderate (>0.3 < 0.6), poor (<0.3).
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Table 5 – Comparative HGDIs of 8 highly discriminatory MIRU loci for all MTB strains, CAS and non-CAS MTB strains.
Loci All strains (N = 200) CAS strains (n = 113) Non-CAS strains (n = 87) P-value
Qub 26 0.826 0.807 0.841 0.235
10 0.807 0.699 0.835 0.00*
26 0.797 0.686 0.854 0.00*
4156 0.784 0.699 0.775 0.004*
Mtub04 0.777 0.742 0.721 0.004*
16 0.749 0.672 0.755 0.001*
31 0.727 0.712 0.745 0.056
ETR A 0.613 0.425 0.75 0.046*
DI of 8 loci set 0.76 0.680 0.784 0.03*
* DI of 8 highly discriminatory loci set of CAS and other than CAS strains was higher than 15 loci set for CAS and non-CAS strains and it was
significantly different.
Table 6a – Comparative HGDIs of 15 MIRU loci of Sensitive, MDR and XDR CAS and Non-CAS MTB strains.
Loci CAS sensitive
(n = 58)
Non-CAS sensitive
(n = 41)
CAS MDR
(n = 20)
Non-CAS MDR
(n = 21)
CAS XDR
(n = 35)
Non-CAS XDRs
(n = 25)
Qub 26 0.767 0.861 0.821 0.609 0.845 0.846
10 0.631 0.834 0.70 0.652 0.8 0.836
26 0.672 0.693 0.721 0.719 0.705 0.883
4156 0.585 0.770 0.594 0.519 0.796 0.873
Mtub04 0.735 0.703 0.721 0.538 0.758 0.763
16 0.669 0.786 0.531 0.638 0.722 0.790
31 0.673 0.693 0.668 0.728 0.707 0.756
ETR A 0.335 0.791 0.531 0.633 0.507 0.586
40 0.600 0.534 0.468 0.547 0.568 0.763
Mtub39 0.496 0.606 0.568 0.552 0.467 0.716
Mtub21 0.439 0.761 0.194 0.685 0.431 0.516
Mtub30 0.448 0.625 0.568 0.490 0.384 0.600
ETR C 0.163 0.619 0.278 0.471 0.112 0.680
Qub 11b 0.227 0.607 0.268 0.423 0.161 0.706
4 0.068 0.428 0.00 0.00 0.00 0.296
DI of 15 loci set 0.500 0.687 0.508 0.546 0.530 0.707
P-value 0.006* 0.613 0.037*
* DI of 15 loci set between CAS and other than CAS is significantly different.
Table 6b – Comparative HGDIs of 8 highly discriminatory MIRU loci for sensitive, MDR and XDR CAS and non-CAS MTB
strains.
Loci CAS sensitive
(n = 58)
Non-CAS sensitive
(n = 41)
CAS MDR
(n = 20)
Non-CAS MDR
(n = 21)
CAS XDR
(n = 35)
Non-CAS XDRs
(n = 25)
Qub 26 0.767 0.861 0.821 0.609 0.845 0.846
10 0.631 0.834 0.70 0.652 0.8 0.836
26 0.672 0.693 0.721 0.719 0.705 0.883
4156 0.585 0.770 0.594 0.519 0.796 0.873
Mtub 04 0.735 0.703 0.721 0.538 0.758 0.763
16 0.669 0.786 0.531 0.638 0.722 0.790
31 0.673 0.693 0.668 0.728 0.707 0.756
ETR-A 0.335 0.791 0.531 0.633 0.507 0.586
DI of 8 loci set 0.633 0.766 0.660 0.629 0.730 0.791
P-value* 0.023 0.494 0.235
* DI of 8 loci set between sensitive CAS and non-CAS isolates was significantly different (P value = 0.023). Whereas difference in DI of MDR and
XDR isolates was insignificant.
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MIRU loci set for all isolates was 0.620 which was highly dis-
criminatory, at 0.620 (Table 3). Eight out of 15 loci (Qub 26b, 10,
26, 4156, Mtub 04, 16, 31 and ETR-A) were highly discrimina-
tory. Six loci were moderately discriminatory, while MIRU 4
was poorly discriminatory.
Allelic diversity of 15 MIRU loci for CAS and other than CAS
strains
Allelic diversity for each of the 15 MIRU loci was analyzed
separately for CAS and other than CAS strains (Table 4, Sup-
plementary Files 3 and 4). For CAS strains, 7 out of 15 loci
(Qub 26b, 10, 26, 4156, Mtub 04, 16 and 31) were highly dis-
criminatory. Loci ETR-A, 40, Mtub39, Mtub21 and Mtub30 were
moderately discriminatory, while ETR-C, Qub11 and MIRU 4
were poorly discriminatory. For non-CAS strains, 12 out of
15 loci (10, 16, 26, 31, 40, Mtub 04, 4156, Qub 26b, ETR-A,
ETR-C, Mtub21 and Mtub39) were highly discriminatory; loci
Qub11, and Mtub 30 were moderately discriminatory; and
MIRU 4 remained poorly discriminatory.
The HGDI of standard 15 MIRU loci set for CAS was
significantly lower as compared with non-CAS isolates (P
value = 0.023). For each MIRU loci, allelic variability was com-
pared between CAS and non-CAS isolates and showed that
HGDI of loci 26, 4156, Mtub4, 16, ETR-A, Mtub39, Mtub21,
ETR-C, Qub11b and 4 was significantly different between
groups.
Allelic diversity of 8 highly discriminatory MIRU loci
Allelic diversity of Pakistani isolates was further analyzed
using only the 8 highly discriminatory loci (Qub26, MIRU 10,
16, 4256, Mtub 04, 16, 31 and ETR-A). The average HGDI based
on these 8 loci for all MTB isolates was 0.76 (Table 5). Sepa-
rately, the average HGDI of CAS and non-CAS strains was
0.680 and 0.784, respectively (Table 5).
Allelic diversity of 15 and 8 MIRU loci for susceptible and drug
resistant CAS and non-CAS isolates
To investigate a possible association between MIRU types and
drug susceptibility, discriminatory loci analysis was per-
formed for both standard 15 loci set and selected 8 loci set
typing by comparing MIRU profiles of drug susceptible, MDR
and XDR strains belonging to both CAS and non-CAS lineages.
Based on 15 loci typing, the average DI for CAS strains, drug
susceptible, MDR and XDR strains was comparable (HGDI:
0.500, 0.508 and 0.530, respectively) (Table 6a). Similarly, for
non-CAS isolates, HGDI for susceptible, MDR and XDR isolates
was also comparable (HGDI: 0.687, 0.546 and 0.707, respec-
tively). Based on 8 loci MIRU typing, the average DI for CAS
susceptible, MDR and XDR strains was 0.633, 0.660 and
0.730, respectively, and HGDI for non-CAS strains was 0.766,
0.629 and 0.791, respectively (Table 6b).
Discussion
In this study, 15 loci-based MIRU-VNTR typing was used to
identify similarities between 200 clinical MTB isolates from
Pakistan comprising CAS and non-CAS lineage strains. It
was found that the discriminatory power of MIRU-based anal-
ysis varied depending on the lineage of MTB strains. Also, it
was observed that MIRU-VNTR together with spoligotyping
enhanced the discrimination of MTB strains in the popula-
tion, supporting previous reports [23]. Comparative analysis
of MIRU-VNTRs for CAS and non-CAS isolates revealed the
CAS lineage to be less diverse. The least diverse VNTRs
(HGDI < 0.1) for CAS strains were loci 4, Qub11b and ETR-C.
This finding is consistent with other studies which suggested
that low diversity in these loci may be due to greater genetic
stability for strains, as found for the CAS1 lineage [16,24–26].
ETR-C was found to be highly discriminatory in this study
of non-CAS strains. Conversely, Qub11b was poorly discrimi-
natory for CAS, but moderately discriminatory for Beijing
strains. Consistent with these findings, Qub11b has been
reported as being highly discriminatory for other than CAS,
including Beijing strains from Russia and China; conversely,
it has also been reported as poorly discriminatory for Beijing
strains from Japan [16,25,27,28].
In regions with a high prevalence of Beijing strains, inclu-
sion of Mtub 29 and the replacement of ETR-C with MIRU 39 in
the standard 15 loci MIRU-VNTR typing has been recom-
mended for improving the discriminatory power of MIRU-
VNTR [25,29]. In an earlier study based on 12 loci MIRU-VNTR
typing, loci 27 and 39 (in addition to 10, 16 and 31) were iden-
tified as being highly discriminatory for CAS strains [17]. In a
study of CAS strains from India, 7 of the above-mentioned 8
loci (minus ETR-A), in addition to Mtub 21 and MIRU 40, are
proposed for typing while MIRU 4, Qub 11b and ETR-C are
not recommended [30]. This data shows that for CAS lineage
strains, MIRU loci Qub 26b, 10, 26, 4156, Mtub 04, 16, 31 and
ETR-A are highly discriminatory and may be suitable for typ-
ing of CAS strains using fewer loci.
Strains in clusters were predominantly comprised mainly
of CAS drug susceptible strains, but also of Haarlem and Bei-
jing strains. Moreover, clusters with a similar MIRU profile but
different spoligotypes identified in this study is consistent
with findings from India [23]. The lower clustering of resistant
strains is encouraging and suggests that drug resistance may
be due to the acquisition of mutations rather than transmis-
sion of drug resistant strains.
CAS strains are also common in countries neighboring
Pakistan, such as Iran, which has reported 24% of CAS iso-
lates, while studies from India indicate between 46% and
84% of CAS (ST26) strains [15,31,32]. Therefore, the proposed
use of a CAS-selective 8 loci MIRU typing set may allow
improved discriminatory power and provide a cost-effective
MTB genotyping method for tracing infection in hospital
and community settings in all regions where CAS strains
are predominant.
Conclusions
The lower diversity of MIRU loci for CAS lineage as compared
with other than CAS lineages shows greater genetic stability
amongst CAS strains; 8 MIRU loci identified in this study as
being highly discriminatory in an MTB population with pre-
dominant CAS strains may offer an affordable typing method
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to investigate MTB transmission within hospital and commu-
nity settings.
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